Sanofi (FRA:SNW)

-2.65% (1Y)

Market Cap	105.74B
Revenue (ttm)	45.17B
Net Income (ttm)	6.30B
Shares Out	n/a
EPS (ttm)	5.04
PE Ratio	16.79
Forward PE	10.50
Dividend	3.92 (4.47%)
Ex-Dividend Date	May 12, 2025

Volume	9,476
Average Volume	11,654
Open	86.93
Previous Close	87.75
Day's Range	85.75 - 87.16
52-Week Range	85.54 - 110.82
Beta	n/a
RSI	38.22
Earnings Date	Jul 31, 2025

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. The company provides immunology and inflammation, rare diseases, neurology, oncology, and other medicines and vaccines. It also offers poliomyelitis, pertussis, and haemophilus influenzae type b (Hib) pediatric vaccines; respiratory syncytial virus protection and hexavalent combination vaccines protecting against diphtheria, tetanus, pertussis, polio, Hib, and hepatitis B; inf...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 82,878
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: SNW

Financial Performance

In 2024, Sanofi's revenue was 44.29 billion, an increase of 7.73% compared to the previous year's 41.11 billion. Earnings were 5.56 billion, an increase of 2.96%.